Authors: BREITZ H KNOX S WEIDEN P GORIS M MURTHA A BRYAN J AXWORTHY D SEILER C SU FM BEAUMIER P RENO J

Citation: H. Breitz et al., PRETARGETED RADIOIMMUNOTHERAPY(TM) WITH ANTIBODY-STREPTAVIDIN AND Y-90 DOTA-BIOTIN (AVICIDIN(R)) - RESULT OF A DOSE-ESCALATION STUDY, The Journal of nuclear medicine, 39(5), 1998, pp. 272-272

Authors: WESSELS BW BREITZ H MILLS G SIEGEL J STABIN M WESSELS BW

Citation: Bw. Wessels et al., THE 10TH INTERNATIONAL-CONFERENCE ON MONOCLONAL-ANTIBODY IMMUNOCONJUGATES FOR CANCER - RADIODOSIMETRY AND RADIOPHARMACEUTICALS FOR THERAPY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(1), 1996, pp. 25-42

Authors: BREITZ H SELLER C WEIDEN P APPELBAUM J RATLIFF B STIEKEMA J KLEIN J RUPPEL S DEJAGER R

Citation: H. Breitz et al., RE-186 LABELED 16.88-IGM AND 88BV59 IGG HUMAN-ANTIBODY STUDIES TO ASSESS POTENTIAL FOR RADIOIMMUNOTHERAPY, The Journal of nuclear medicine, 35(5), 1994, pp. 160000100-160000100

Authors: BREITZ H

Citation: H. Breitz, WALL DOSE ESTIMATES - REPLY, The Journal of nuclear medicine, 35(1), 1994, pp. 191-191

Authors: JACOBS AJ FER M SU FM BREITZ H THOMPSON J GOODGOLD H CAIN J HEAPS J WEIDEN P

Citation: Aj. Jacobs et al., A PHASE-I TRIAL OF A RHENIUM 186-LABELED MONOCLONAL-ANTIBODY ADMINISTERED INTRAPERITONEALLY IN OVARIAN-CARCINOMA - TOXICITY AND CLINICAL-RESPONSE, Obstetrics and gynecology, 82(4), 1993, pp. 586-593